Pharmacokinetics, Safety, and Efficacy of Cobicistat-boosted Atazanavir or Cobicistat-boosted Darunavir in HIV-1 Infected, Treatment-Experienced, Virologically Suppressed Pediatric Subjects

This study is currently recruiting participants. (see Contacts and Locations)
Verified November 2015 by Gilead Sciences
Information provided by (Responsible Party):
Gilead Sciences Identifier:
First received: December 16, 2013
Last updated: November 2, 2015
Last verified: November 2015
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2024
  Estimated Primary Completion Date: December 2020 (Final data collection date for primary outcome measure)